Cultivating Leadership Teams up with The Core Questin to get Indian C-Suite Future-ready
Cultivating Leadership, a global organisation renowned for its work in leadership development,…
Aramco plans to enter Philippines retail market with agreement to acquire 25% stake in Unioil
Aramco to extend brand, retail offerings and Valvoline-branded lubricants to select retail…
AGCO and SDF Enter New Partnership to Strengthen Global Position in Low-Mid Horsepower Tractor Segment
Supply agreement enables a refreshed Massey Ferguson utility tractor range DULUTH, Ga.…
Cubresa and Siemens Healthineers Sign Global Master Interface Agreement for the Cubresa BrainPET Scanner
WINNIPEG, MB, Feb. 11, 2025 /PRNewswire/ -- Cubresa is pleased to announce…
Kinectrics and Isotopia Enter Agreement for Supply of Gadolinium-160 (Gd-160) to Support Production of Terbium-161 (Tb-161) for Advanced Radiotherapeutics
TORONTO, Jan. 30, 2025 /PRNewswire/ -- Kinectrics and Isotopia have announced a…
Nadcab Labs’ White-Label Crypto Exchanges Empower Startups to Compete Globally
NEW DELHI, Jan. 20, 2025 /PRNewswire/ -- Nadcab Labs, is redefining how startups…
Menarini Group and Insilico Medicine Enter a Second Exclusive Global License Agreement for an AI Discovered Preclinical Asset Targeting High Unmet Needs in Oncology
This is the second asset Menarini Group has inlicensed from Insilico Medicine…
Menarini Group and Insilico Medicine Enter a Second Exclusive Global License Agreement for an AI Discovered Preclinical Asset Targeting High Unmet Needs in Oncology
This is the second asset Menarini Group has inlicensed from Insilico Medicine…
Gilead and LEO Pharma Enter Into Strategic Partnership to Accelerate Development of Oral STAT6 Program With Potential in Multiple Inflammatory Diseases
-- Strategic Partnership Strengthens Gilead’s Inflammation Research Portfolio with the Addition of…
Menarini Group and Insilico Medicine Enter a Second Exclusive Global License Agreement for an AI Discovered Preclinical Asset Targeting High Unmet Needs in Oncology
This is the second asset Menarini Group has inlicensed from Insilico Medicine…